(NASDAQ: NOTV) Inotiv's forecast annual revenue growth rate of 4.57% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.2%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.8%.
Inotiv's revenue in 2025 is $480,402,000.On average, 1 Wall Street analysts forecast NOTV's revenue for 2025 to be $16,992,013,508, with the lowest NOTV revenue forecast at $16,992,013,508, and the highest NOTV revenue forecast at $16,992,013,508. On average, 1 Wall Street analysts forecast NOTV's revenue for 2026 to be $18,023,633,437, with the lowest NOTV revenue forecast at $18,023,633,437, and the highest NOTV revenue forecast at $18,023,633,437.
In 2027, NOTV is forecast to generate $19,121,554,614 in revenue, with the lowest revenue forecast at $19,121,554,614 and the highest revenue forecast at $19,121,554,614.